Cantabio Pharmaceuticals Inc
OTC:CTBO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cantabio Pharmaceuticals Inc
OTC:CTBO
|
US |
|
C
|
Cosigo Resources Ltd
OTC:COSRF
|
CA |
|
N
|
North American Construction Group Ltd
F:N5Z
|
CA |
|
Tambovskaya Energosbytovaya Kompaniya PAO
MOEX:TASB
|
RU |
|
Shandong Fiberglass Group Co Ltd
SSE:605006
|
CN |
|
F
|
Futuristic Solutions Ltd
BSE:534063
|
IN |
|
J
|
JM Holdings Co Ltd
TSE:3539
|
JP |
|
G
|
Greenridge Exploration Inc
OTC:GXPLF
|
CA |
Profitability Summary
Cantabio Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Cantabio Pharmaceuticals Inc
Margins Comparison
Cantabio Pharmaceuticals Inc Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| US |
|
Cantabio Pharmaceuticals Inc
OTC:CTBO
|
19.5k USD |
Loading...
|
Loading...
|
|
| KR |
S
|
Samsung Epis Holdings Co Ltd
KRX:0126Z0
|
12.4T KRW |
Loading...
|
Loading...
|
|
| US |
M
|
Metsera Inc
NASDAQ:MTSR
|
7.4B USD |
Loading...
|
Loading...
|
|
| DE |
A
|
Anbio Biotechnology
NASDAQ:NNNN
|
3.7B USD |
Loading...
|
Loading...
|
|
| US |
B
|
BillionToOne Inc
NASDAQ:BLLN
|
3.6B USD |
Loading...
|
Loading...
|
|
| CN |
T
|
TransThera Sciences (Nanjing) Inc
HKEX:2617
|
27.8B HKD |
Loading...
|
Loading...
|
|
| US |
|
Alumis Inc
NASDAQ:ALMS
|
2.9B USD |
Loading...
|
Loading...
|
|
| US |
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
2.6B USD |
Loading...
|
Loading...
|
|
| US |
V
|
Veradermics Inc
NYSE:MANE
|
2.3B USD |
Loading...
|
Loading...
|
|
| US |
|
Grail Inc
NASDAQ:GRAL
|
2.2B USD |
Loading...
|
Loading...
|
|
| CN |
N
|
Nanjing Leads Biolabs Co Ltd
HKEX:9887
|
16.8B HKD |
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Cantabio Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
|
Cantabio Pharmaceuticals Inc
OTC:CTBO
|
19.5k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
S
|
Samsung Epis Holdings Co Ltd
KRX:0126Z0
|
12.4T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
M
|
Metsera Inc
NASDAQ:MTSR
|
7.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
A
|
Anbio Biotechnology
NASDAQ:NNNN
|
3.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
BillionToOne Inc
NASDAQ:BLLN
|
3.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
T
|
TransThera Sciences (Nanjing) Inc
HKEX:2617
|
27.8B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alumis Inc
NASDAQ:ALMS
|
2.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
2.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
V
|
Veradermics Inc
NYSE:MANE
|
2.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Grail Inc
NASDAQ:GRAL
|
2.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
N
|
Nanjing Leads Biolabs Co Ltd
HKEX:9887
|
16.8B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
